Life sciences news
-
Galapagos announces departure of CSO Piet Wigerinck later this year
Wednesday June 23rd 2021
Read more
-
Biotalys launches its Initial Public Offering on Euronext Brussels
Wednesday June 23rd 2021
Read more
-
Janssen Pharmaceutica NV plant eerste Europese productiecentrum voor celtherapie in België
Tuesday June 22nd 2021
Read more
-
Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy
Tuesday June 22nd 2021
Read more
-
Estelle® oral contraceptive now available in the United States
Monday June 21st 2021
Read more
-
Mithra completes recruitment of Covid-19 Phase II Study
Thursday June 17th 2021
Read more
-
Biotalys’ ongoing trial program demonstrates strong potential of its new generation protein-based biocontrols
Thursday June 17th 2021
Read more
-
argenx announces publication of Phase 3 ADAPT trial results of efgartigimod for the treatment of generalized myasthenia gravis in The Lancet Neurology
Thursday June 17th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Biocair moves into new Frankfurt office, continuing global expansion
Thursday June 17th 2021
Read more
-
Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd.
Wednesday June 16th 2021
Read more
-
Biotalys announces intention to launch an Initial Public Offering on Euronext Brussels
Tuesday June 15th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
